
184.82 Delayed Data As of Nov 28 | ![]() Today’s Change | 156.56 Today|||52-Week Range 280.62 | -15.97% Year-to-Date |
The Zacks Analyst Blog Highlights Gilead Sciences, Legend Biotech, BeiGene, Exact Sciences and Sarepta Therapeutics Nov 21 / Zacks.com - Paid Partner Content | 5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024 Nov 20 / Zacks.com - Paid Partner Content |
Previous close | 182.96 |
Today’s open | 181.60 |
Day’s range | 181.28 - 185.00 |
Volume | 104,101 |
Average volume (3 months) | 223,235 |
Market cap | -- |
Earnings growth (last year) | -27.55% |
Earnings growth (this year) | +36.40% |
Earnings growth (next 5 years) | -39.43% |
Revenue growth (last year) | +20.37% |
P/E ratio | NM |
Price/Sales | 16.02 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
TEVATeva Pharmaceutical | +0.00 | +0.05% |
BBIOBridgeBio Pharma Inc | -0.95 | -3.19% |
IDRSFIdorsia Ltd | 0.00 | 0.00% |
---- |
Next reporting date | March 27, 2024 |
EPS forecast (this quarter) | -$3.12 |
Annual revenue (last year) | $1.4B |
Annual profit (last year) | -$2.0B |
Net profit margin | -141.52% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters George Town, George Town |